About: Dermatological diseases presented before COVID‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID‐19?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dermatological diseases presented before COVID‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID‐19? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Dermatological diseases presented before COVID‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID‐19?
Creator	Kutlu, Ömer Metin, Ahmet
source	Medline; PMC; WHO
abstract	Recent studies have focused on the comorbid conditions of the COVID‐19. According to the current studies, numerous diseases including lung disease, cardiovascular disease, and immunosuppression appear to be at higher risk for severe forms of the COVID‐19. To date, there are no data in the literature on the comorbid dermatologic diseases and COVID‐19. We tried to analyze the previous dermatological comorbidity of 93 patients with COVID‐19 (51 males, 42 females) who presented to the dermatology outpatient clinics for the last 3 years. The most common dermatologic diseases in patients with COVID‐19 who have dermatologic diseases for the last three years were superficial fungal infections (24, 25.8%), seborrheic dermatitis (11, 11.8%), actinic keratosis (10, 10.8%), psoriasis (6, 6.5%) and eczema (6, 6.5%), respectively. In addition, the number of COVID‐19 patients who presented to dermatology in the last three months was 17 (11 men, 6 women). The median age of these patients was 58 (minimum 18, maximum 80) years, and the most common dermatologic diseases before diagnosed COVID‐19 were superficial fungal infections (5, 25%), psoriasis (4, 20%), and viral skin diseases (3, 15%). The possible similarity between cutaneous and mucosal immunity and immunosuppression suggests that patients with some dermatologic diseases especially superficial fungal infections and psoriasis may be more vulnerable to the COVID‐19. This article is protected by copyright. All rights reserved.
has issue date	2020-05-05(xsd:dateTime)
bibo:doi	10.1111/dth.13509
bibo:pmid	32367558
has license	no-cc
sha1sum (hex)	f713e5bd528ce6fa342f8a0a3358984737f4b2c4
schema:url	https://doi.org/10.1111/dth.13509
resource representing a document's title	Dermatological diseases presented before COVID‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID‐19?
has PubMed Central identifier	PMC7261987
has PubMed identifier	32367558
schema:publication	Dermatol Ther
resource representing a document's body	covid:f713e5bd528ce6fa342f8a0a3358984737f4b2c4#body_text
is schema:about of	named entity 'COVID-19' named entity 'FOCUSED' named entity 'HAVE' named entity 'comorbid' named entity 'comorbid conditions' named entity 'COVID-19' named entity 'Recent studies' named entity 'psoriasis' named entity 'immunosuppressive' named entity 'seborrheic dermatitis' named entity 'antiviral' named entity 'dermatologic' named entity 'biological agents' named entity 'immunosuppression' named entity 'dermatologic' named entity 'Th17' named entity 'secretory IgA' named entity 'comorbid' named entity 'cardiovascular disease' named entity 'COVID-19' named entity 'methotrexate' named entity 'dermatology' named entity 'animal study' named entity 'basal layer' named entity 'nasal mucosa' named entity 'intensive care' named entity 'actinic keratosis' named entity 'adaptive immune' named entity 'COVID-19' named entity 'actinic keratosis' named entity 'seborrheic dermatitis' named entity 'immunosuppressive drugs' named entity 'cutaneous' named entity 'neutralizing antibody' named entity 'skin disease' named entity 'COVID-19' named entity 'herpes simplex' named entity 'mucosal immunity' named entity 'immune responses' named entity 'interferon' named entity 'fungal infections' named entity 'COVID-19' named entity 'demographic characteristics' named entity 'dermatology' named entity 'immunosuppressive treatment' named entity 'Descriptive statistics' named entity 'outpatient clinic' named entity 'skin diseases' named entity 'COVID-19' named entity 'SPSS Inc.' named entity 'eczema' named entity 'dermatology' named entity 'mucosal immunity' named entity 'COVID-19' named entity 'Wuhan' named entity 'COVID-19' named entity 'herpes simplex' named entity 'fungal infections' named entity 'dermatologic' named entity 'IFN-α' named entity 'Th1' named entity 'COVID-19' named entity 'normal distribution' named entity 'preventive treatment' named entity 'herpes simplex' named entity 'outpatient clinic' named entity 'COVID-19' named entity 'dermatologic' named entity 'fungal infections' named entity 'dermatology' named entity 'COVID-19 pandemic' named entity 'dermatologic' named entity 'COVID-19' named entity 'diabetes mellitus' named entity 'cutaneous' named entity 'COVID-19' named entity 'COVID-19' named entity 'COVID-19' named entity 'dermatologic' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software